Practice Management News

Artificial intelligence has been used extensively in gastroenterology for polyp detection and is expanding into the inflammatory bowel disease space in an experimental and “research phase,” quickly making its way into clinical use.

Artificial intelligence has been used in various ways to benefit patients with inflammatory bowel disease, with one of the main applications being the prediction and diagnosis of disease.

Patients who underwent bariatric surgery for morbid obesity had a “substantial and long-lasting reduction” of lipid-lowering and antidiabetic medication use compared with patients who did not undergo surgery.

The prospect of managing a lifelong disease can be daunting, and many patients with chronic conditions struggle with consistent health monitoring, treatment adherence and implementing the changes needed to manage their disease.

As the Supreme Court prepares to rule on race-conscious admissions policies at universities, the AMA adopted a new policy of its own that recognizes the importance of considering race in admissions to diversify the workforce.

The AMA adopted policy advocating for greater regulatory oversight of insurers’ use of artificial intelligence at its annual House of Delegates meeting.

Jesse M. Ehrenfeld, MD, MPH, FAMIA, FASA, was recently sworn in as president of the AMA.

Healio will present its sixth annual Disruptive Innovators Awards for gastroenterology and hepatology this fall.

During its House of Delegates meeting, the AMA voted to oppose noncompete agreements for physicians employed by hospitals or staffing company employers.

Many investors have recently been asking their advisors, “Is a recession coming?” This question is often on the minds of investors because the financial media repeatedly brings up the topic.